Facts and Figures
Over the last 40 years over 500,000 patients around the world have been treated with the Gamma Knife.
Our practice went into operation in 1998 and since that time we have already successfully treated more than 3,500 patients. In addition to our medical expertise in the field of neurosurgery and radiosurgery, since 2005 we have also had a Leksell Gamma Knife 4C, which is currently the most technically advanced system of its type in the world.
Statistics of treatment in our centre by indication
| Metastases | 35,4 % |
| Vestibular schwannoma | 22,5 % |
| Meningioma | 21,7 % |
| Choroid melanoma | 5,8 % |
| AVM | 4,2 % |
| Hypophyseal adenoma | 3,1 % |
| Trigeminal neuralgia | 2,9 % |
| Other malignant tumours | 1,7 % |
| Other benign tumours | 1,5 % |
| Gliomas | 0,8 % |
| Glomus jugular tumours | 0,4 % |
Other treatment indicators from our practice
| Medicine | ||
| Efficacy | ||
| Metastasis control rate (short-team) | 92 % | |
| Tumour control rate, benign tumours | 80-100 % | |
| AVM obliteration rate | 72 % |
|
| Occurrence of side-effects | ||
| Metastases | 10 % | |
| Acoustic neurinomas (generally size-dependent) | 5 % | |
| Acoustic neurinomas with hearing loss | 20 % | |
| Other benign tumours | 5 % | |
| AVM | 1 % |
|
| Physical parameters | ||
| Accuracy (phantom measurement incl. imaging) | 0,5 mm | |
| Dose deviation | < 5 % | |
